Comparison the efficacy of amiodarone and lidocaine for cardiac arrest: A network meta-analysis

Author:

Wang Qi1ORCID,Lin Zhen2,Chen Hairong1,Pan Biyun1

Affiliation:

1. Department of General Practice, Central South University Xiangya School of Medicine Affiliated Haikou Hospital, Haikou, China

2. Department of General Practice Geriatrics, Central South University Xiangya School of Medicine Affiliated Haikou Hospital, Haikou, China.

Abstract

Background: There is no evidence that antiarrhythmic drugs can improve long-term survival or survival with favorable neurological outcomes in cardiac arrest patients. We did this network meta-analysis to comprehensively compare the efficacy of various antiarrhythmic drugs for cardiac arrest patients. Methods: We searched studies from inception until Nov 11, 2022 through PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), VIP Database, and Wanfang database. All studies comparing different antiarrhythmic drugs for cardiac arrest were included in this meta-analysis. Outcomes were survival to hospital discharge in cardiac arrest, survival to hospital admission/24 h and favorable neurological outcome. This network meta-analysis was performed by R software. Results: Finally, a total of 9 studies (10,980 patients) were finally included in this network meta-analysis. Amiodarone (odd ratio [OR] 2.28, 95% credibility interval [CrI] 1.61–3.27) and lidocaine (OR 1.53, 95% CrI 1.05–2.25) was superior than placebo in terms of the survival to hospital admission/24 h with statistically significant. Amiodarone (OR 2.19, 95% CrI 1.54–3.14) and lidocaine (OR 1.58, 95% CrI 1.09–2.32) was superior than placebo in terms of the survival to hospital discharge with statistically significant. Amiodarone (OR 2.43, 95% CrI 1.61–3.68) and lidocaine (OR 1.62, 95% CrI 1.04–2.53) was superior than placebo in terms of the favorable neurological outcome with statistically significant. The surface under the cumulative ranking (SUCRA) shows that amiodarone ranked first (SUCRA, 99.6%), lidocaine ranked second (SUCRA, 49.6%), placebo ranked the last (SUCRA, 0.86%). Inverted funnel plot is essentially symmetrical, it is possible that this study has a small sample effect or a small publication bias. Conclusions: Amiodarone had the best effect on both survival to hospital admission, discharge and more favorable neurological outcome. Thus, amiodarone should be listed as first line drug for cardiac arrest. However, the quality of available evidence limits the formation of powerful conclusions regarding the comparative efficacy or safety of amiodarone or lidocaine used to treat cardiac arrest. Higher-quality randomized controlled trials are required for further research in future.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference29 articles.

1. Traumatic cardiac arrest.;Smith;J R Soc Med,2015

2. In-hospital cardiac arrest: a review.;Andersen;JAMA,2019

3. Cardiac arrest and therapeutic hypothermia.;Silverman;Trends Cardiovasc Med,2016

4. Point-of-care ultrasound in cardiac arrest.;Paul;Anesthesiology,2021

5. Outcomes of in-hospital cardiac arrest: a review of the evidence.;DiLibero;Crit Care Nurs Clin North Am,2021

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3